Prostatype Genomics AB (PROGEN) — Working Capital to Net Assets Ratio
Prostatype Genomics AB (PROGEN) has a Working Capital to Net Assets ratio of 19.2% as of June 2025. Working capital of Skr7.01 Million (current assets of Skr14.37 Million minus current liabilities of Skr7.36 Million) is measured against net assets of Skr36.48 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See PROGEN defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Prostatype Genomics AB Working Capital to Net Assets (2015–2024)
This chart shows how Prostatype Genomics AB's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2015 to 2024. As of June 2025, the ratio stands at 19.2%, reflecting working capital of Skr7.01 Million against net assets of Skr36.48 Million SEK. For the complete balance sheet picture, see PROGEN total assets.
Annual Working Capital to Net Assets for Prostatype Genomics AB (2015–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Prostatype Genomics AB from 2015 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Prostatype Genomics AB asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 9.9% | Skr3.32 Million | Skr33.47 Million | Skr11.82 Million | Skr8.50 Million | ▲ +4.1 pp |
| 2023 | 5.8% | Skr1.43 Million | Skr24.67 Million | Skr25.91 Million | Skr24.48 Million | ▼ -31.8 pp |
| 2022 | 37.6% | Skr9.84 Million | Skr26.15 Million | Skr14.17 Million | Skr4.33 Million | ▼ -13.0 pp |
| 2021 | 50.6% | Skr18.15 Million | Skr35.91 Million | Skr21.59 Million | Skr3.43 Million | ▲ +4.1 pp |
| 2020 | 46.5% | Skr13.15 Million | Skr28.29 Million | Skr17.46 Million | Skr4.31 Million | ▲ +24.2 pp |
| 2018 | 22.2% | Skr1.90 Million | Skr8.55 Million | Skr4.48 Million | Skr2.58 Million | ▼ -70.4 pp |
| 2017 | 92.6% | Skr5.76 Million | Skr6.22 Million | Skr9.70 Million | Skr3.94 Million | ▲ +36.3 pp |
| 2016 | 56.3% | Skr8.41 Million | Skr14.93 Million | Skr11.17 Million | Skr2.76 Million | ▲ +195.1 pp |
| 2015 | -138.7% | Skr1.83 Million | Skr-1.32 Million | Skr3.43 Million | Skr1.60 Million | — |